Human Influenza Virus Real-time RT-PCR: Detection and Discrimination of Influenza A (H3N2) Variant from Seasonal Influenza A (H3N2) Viruses, Including H3v and Seasonal H3 Assays

Description:
This invention relates to methods of rapidly detecting influenza, including differentiating between type and subtype. CDC researchers have developed a rapid, accurate, real-time RT-PCR assay that has several advantages over culture and serological tests, which require 5 to 14 days for completion; this assay can also be easily implemented in kit form. To date, hundreds of human cases of infection with the H3N2 variant virus have been confirmed. The increased numbers of human infection of H3N2 variant virus has led to a need for a highly sensitive and specific assay for the diagnosis and confirmation of the H3N2 variant virus.
Patent Information:
For Information, Contact:
Jeremiah Mitzelfelt
NIH Technology Transfer
301-443-8518
jeremiah.mitzelfelt@nih.gov
Inventors:
Stephen Lindstrom
Kai-Hui Wu
LaShondra Berman
Bo Shu
Keywords:
assay
ASSAYS
CDC Docket Import
CDC Docket Import CDC Prosecuting
CIRCULATING
DA4BXX
DA4XXX
DAXXXX
Detection
diagnostic
Diagnostic assay
diagnostic in vitro
discrimination
DXXXXX
Flu
H3
H3N2
H3v
Including
INFLUENZA
ivd
Pandemic
REAL-TIME
RT-PCR
Seasonal
VARIANT
virus
Viruses
VLXXXX
VOXXXX
WBXXXX
WFXXXX
WIXXXX
WMXXXX
XCXXXX
XEXXXX
YBXXXX
© 2024. All Rights Reserved. Powered by Inteum